Reuters logo
Pfizer says clotting drug's once-weekly dose reduces bleeding rate
July 16, 2014 / 12:15 PM / 3 years ago

Pfizer says clotting drug's once-weekly dose reduces bleeding rate

July 16 (Reuters) - Pfizer Inc said a once-weekly dose of its drug, already approved for on-demand treatment of a blood clotting disorder, reduced bleeding rates in patients in a late-stage study.

Hemophilia B patients taking the drug, BeneFIX, once a week showed a statistically significant reduction in the annualized bleeding rate compared with those administered the drug on demand. (Reporting by Shailesh Kuber in Bangalore; Editing by Kirti Pandey)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below